Omonan, Clarence Mae P.
HRN: 25 51 35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2024
CEFUROXIME 1.5GM (VIAL)
07/17/2024
07/23/2024
IV
1.5gm
Q8
Uncomplicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No
Final appropriateness: Yes
Overall appropriateness: Yes